WHO ICTRP trial
A PHASE 2, RANDOMIZED, DOUBLE-MASKED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY…
EUCTR2010-018741-65-LV · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-018741-65-LV |
|---|---|
| Public title | A PHASE 2, RANDOMIZED, DOUBLE-MASKED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREOUS INJECTIONS OF E10030 (ANTI-PDGF PEGYLATED APTAMER) GIVEN IN COMBINATION WITH LUCENTIS® IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - REGRESS |
| Scientific title | A PHASE 2, RANDOMIZED, DOUBLE-MASKED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREOUS INJECTIONS OF E10030 (ANTI-PDGF PEGYLATED APTAMER) GIVEN IN COMBINATION WITH LUCENTIS® IN SUBJECTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION - REGRESS |
| Primary sponsor | OPHTHOTECH CORPORATION |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Germany;Colombia;Belgium;France;Spain;Italy;Latvia;Austria;Israel |
| Conditions | Subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD) MedDRA version: 14.1 Level: LLT Classification code 10067791 Term: Wet macular degeneration System Organ Class: 10015919 - Eye disorders MedDRA… |
| Interventions | Product Name: E10030 Product Code: E10030 Pharmaceutical Form: Solution for injection Current Sponsor code: E10030 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 30- Product Name: E10030… |
| Registration date | Aug 3, 2010 |
| Target size | 444 |
| Secondary IDs | OPH1001A;NCT01089517 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: